Cited by 379TGF-β signaling in diseasesCancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

The DOI matches its Crossref record; 318 of the 320 references it cites were found in a registry or an index.

Overcoming TGFβ-mediated immune evasion in cancer

Tauriello, Daniele V. F., Sancho, Elena, Batlle, Eduard·2022·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Transforming growth factor-β (TGFβ) signalling controls multiple cell fate decisions during development and tissue homeostasis; hence, dysregulation of this pathway can drive several diseases, including cancer. Here we discuss the influence that TGFβ exerts on the composition and behaviour of different cell populations present in the tumour immune microenvironment, and the context-dependent functions of this cytokine in suppressing or promoting cancer. During homeostasis, TGFβ controls inflammatory responses triggered by exposure to the outside milieu in barrier tissues. Lack of TGFβ exacerbates inflammation, leading to tissue damage and cellular transformation. In contrast, as tumours progress, they leverage TGFβ to drive an unrestrained wound-healing programme in cancer-associated fibroblasts, as well as to suppress the adaptive immune system and the innate immune system. In consonance with this key role in reprogramming the tumour microenvironment, emerging data demonstrate that TGFβ-inhibitory therapies can restore cancer immunity. Indeed, this approach can synergize with other immunotherapies - including immune checkpoint blockade - to unleash robust antitumour immune responses in preclinical cancer models. Despite initial challenges in clinical translation, these findings have sparked the development of multiple therapeutic strategies that inhibit the TGFβ pathway, many of which are currently in clinical evaluation.

Integrity signals

Registry

Crossref · 10.1038/s41568-021-00413-6

Cites

318 of 318 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells
Shen, M., Tsai, Y., Zhu, R., Keng, P. C., Chen, Y., Chen, Y., & Lee, S. O. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.12.012 · Cited by 23
Retracted
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
Chen, W., Jin, W., Hardegen, N. J., Lei, K.-J., Li, L., Marinos, N. J., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,678
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148

Show all 320 references

Sorted by citations

Items 201–300 of 379

From immune suppression to immunotherapy sensitization: the dual roles of circRNAs in cancer progression
Dai, Q., Yuan, X., Dong, H., & Xue, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1723383 · Cited by 5
Synergistic STING activation and oxidative cascades-induced ferroptosis drive tumor microenvironment remodeling by engineered manganese nanoreactors
Li, W., Tang, Z., & Xue, J. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103977 · Cited by 5
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
Zhang, Q., Fu, Q., Shen, Y., Cao, W., Jin, G., Zhang, Y., Wu, J., Chen, C., Wang, H., Xu, X., et al. (2026) · Nature · doi:10.1038/s41586-026-10786-z · Cited by 5
Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma
Liang, S., Ji, L., Yu, Z., Cheng, Y.-H., Gao, R., Yan, W., & Zhang, F. (2024) · Hereditas · doi:10.1186/s41065-024-00311-5 · Cited by 5
Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma
Yang, H., Chen, Y., Huang, X., Gu, Y., Chen, Z., & Mao, W. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.93423 · Cited by 5
HNF4A Defines Molecular Subtypes and Vulnerability to Transforming Growth Factor β-Pathway Targeted Therapies in Cancers of the Distal Esophagus
Blum, A. E., Ravillah, D., Singh, S., Miao, Y., Kresak, A. M., Willis, J. E., Canto, M. I., Wang, J. S., Shaheen, N. J., Chak, A., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.07.073 · Cited by 5
Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
Chu, B., Zheng, H., Zheng, X., Feng, X., & Hong, Z. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.989882 · Cited by 5
Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy
Chen, J., Ji, C., Liu, S., Wang, J., Wang, C., Pan, J., Qiao, J., Yu, L., Cai, M., & Ma, J. (2023) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2023.12.002 · Cited by 5
Evaluation of Potential Furin Protease Inhibitory Properties of Pioglitazone, Rosiglitazone, and Pirfenidone: An In Silico Docking and Molecular Dynamics Simulation Approach
Carranza-Aranda, A. S., Díaz-Palomera, C. D., Lepe-Reynoso, E., Santerre, A., Muñóz-Valle, J. F., & Segura, O. V. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46080511 · Cited by 5
New Potent Inhibitor of Transforming Growth Factor-Beta (TGFβ) Signaling that is Efficacious against Microsatellite Stable Colorectal Cancer Metastasis in Combination with Immune Checkpoint Therapy in Mice
Tauriello, D. V. F., Sancho, E., Byrom, D., Sánchez, C., Salvany, M., Henriques, A. R., Palomo‐Ponce, S., Sevillano, M., Hernando‐Momblona, X., Matarin, J. A., et al. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00374 · Cited by 5
Self-citation
The application of antibody-based agents in cancer therapy based on their mechanisms of action
Qian, K., Li, G., Zhang, S., Zou, Y., Ai, H., Zheng, X., Fu, W., Lei, C., & Hu, S. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.02.021 · Cited by 6
TGF-β signaling in organoids: The mechanisms and applications in 3D
Zhu, S., Liu, J., Qiu, X., Cai, G., & Gao, M. (2025) · Cell organoid (Print) · doi:10.26599/co.2025.9410015 · Cited by 4
TMEM16F phospholipid scramblase regulates tumorigenesis by modulating the tumor immune microenvironment
Wu, M., Shi, P., Huang, J., Ni, X., Lai, R., Cao, K., Cai, M., Yu, H., Zhao, W., & Zhang, Y. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2513910122 · Cited by 4
The Function of the TGFβ Signaling Pathway in Connective Tissue Diseases: From Biology to Clinical Application
Yuan, S., Zhu, W., Wang, Y., & Yu, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s539571 · Cited by 5
Recent advances and future prospects of immunotherapeutic approaches in prostate cancer
Wang, N., Wang, C., Cui, S., Zhao, K., Zhang, J., Zhang, L., Jia, Y., & Kong, F. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07720-2 · Cited by 5
Pan-cancer characterization of cellular senescence reveals its inter-tumor heterogeneity associated with the tumor microenvironment and prognosis
Li, K., Guo, C., Li, R., Yao, Y., Qiang, M., Chen, Y., Tu, K., & Xu, Y. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109196 · Cited by 4
Discovery and preclinical evaluation of BPB-101: a novel triple functional bispecific antibody targeting GARP-TGF-β complex/SLC, free TGF-β and PD-L1
Xu, W., Xu, J., Li, P., Xu, D., Cheng, H., Zheng, H., Zhang, L., Liu, M., Ye, S., Jiang, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1479399 · Cited by 5
Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy
Wu, S., Wu, Z., Lu, Z., Qi, F., Jin, C. S., Chu, T., Li, B., Zhao, Y., Nie, G., & Li, S. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101984 · Cited by 4
Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer
Yuan, J., Beibei, X., Su, Y., Zhang, P., Zhang, X., & Gong, P. (2025) · BMC Cancer · doi:10.1186/s12885-025-14096-x · Cited by 4
The Relationships Among Perineural Invasion, Tumor–Nerve Interaction and Immunosuppression in Cancer
Dudás, J., Glueckert, R., Greier, M. D. C., & Hofauer, B. G. (2025) · Onco · doi:10.3390/onco5020025 · Cited by 4
GABRP Mediates GABA ‐A Receptor to Shape Tumor Immunosuppressive Microenvironment and Promote Tumor Immune Escape and Corresponding Targeted Therapy
Cen, W., Fu, G., Wang, X., Wei, R., Zhou, X., Teng, W., Ling, Y., Tang, J., Wang, Z., & Chu, L. (2025) · Cancer Medicine · doi:10.1002/cam4.70946 · Cited by 6
Engineering DNA Origami Captors for TGFβ1 Sequestration to Enhance Tumor Immune Modulation and Therapy
Chen, X., Liu, D., Jin, J., Yao, H., Yao, S., Liu, Y., Sun, J., & Yang, Y. (2025) · Advanced Science · doi:10.1002/advs.202506827 · Cited by 5
Diverse Biological Processes Contribute to Transforming Growth Factor β-Mediated Cancer Drug Resistance
Heiserman, J. P., & Akhurst, R. J. (2025) · Cells · doi:10.3390/cells14191518 · Cited by 4
Identification of key immune cells infiltrated in lung adenocarcinoma microenvironment and their related long noncoding RNA
Wang, K., Yan, T., Guo, D., Sun, S., Liu, Y., Liu, Q., Wang, G., Chen, J., & Du, J. (2024) · iScience · doi:10.1016/j.isci.2024.109220 · Cited by 4
Identifying CTH and MAP1LC3B as ferroptosis biomarkers for prognostic indication in gastric cancer decoding
Qu, H., Liang, Y., Guo, Q., Lu, L., Yang, Y., Xu, W., Zhang, Y., & Qin, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-54837-9 · Cited by 4
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma
Crucitta, S., Cucchiara, F., Marconcini, R., Bulleri, A., Manacorda, S., Capuano, A., Cioni, D., Nuzzo, A., de Jonge, E., Mathijssen, R. H. J., et al. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1288677 · Cited by 4
Exploring the relation between TGF-β pathway activity and response to checkpoint inhibition in patients with metastatic melanoma
van Ravensteijn, S. G., Amir, A. L., Tauriello, D. V. F., van Herpen, C. M. L., Boers‐Sonderen, M. J., Wesseling-Rozendaal, Y. J. W., van Brussel, A., Keizer, D. M., Verheul, H. M. W., & Bol, K. F. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae108 · Cited by 5
Self-citation
Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy
Li, X., Cheng, Y., Ji, M., Liu, J., Zhao, Z., & Zhao, Q. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04083-3 · Cited by 4
Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas
Rong, C., Liu, Y., Fang, X., Zhao, X., Zhang, J., Xiao, Z., Wang, J., Chen, L., Guo, Z., Zhang, Z., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01064-8 · Cited by 4
Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment
Wang, F., Lu, S., Zhou, X., Di, X., Wu, R., Chen, G., & Tian, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1103741 · Cited by 3
Identifying a Novel Eight-NK Cell-related Gene Signature for Ovarian Cancer Prognosis Prediction
Li, N., Yu, K., Huang, D., Zhou, H., & Zeng, D. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230831101847 · Cited by 4
TGFβ signaling activation correlates with immune-inflamed tumor microenvironment across human cancers and predicts response to immunotherapy
Xia, J., Zhang, Q., Luan, J., Min, P., Zhang, H., Chen, G., Ji, C., & Song, N. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2109105 · Cited by 4
The Heat Is On: 20-HETE Instructs an Immunosuppressive Phenotype in Cancer-Associated Fibroblasts
Ginderachter, J. A. V. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2774 · Cited by 4
Testing the plasticity-first theory of tumor evolution with spatiotemporal lineage tracingPreprint
Yang, J., Hou, L., Wang, X., Zhang, N., Bian, Y., Lu, Z., Chen, Y., Xie, D., Fang, Y., Wang, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.06.668639 · Cited by 4
Glycolysis Inhibition Restores Immune Sensitivity in GSNOR–Deficient Colorectal Cancer
Mantrana, A., Sánchez-Montero, M. T., Navarrete‐Sirvent, C., Herrera‐Casanova, N. M., Mena‐Osuna, R., Rivas‐Crespo, A., Díaz‐Chacón, A., Ávila-Oca, V., Toledano‐Fonseca, M., García‐Ortiz, M. V., et al. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104250 · Cited by 3
Indole propionic acid modulates macrophage polarization via TGF-β1/smads to enhance E-cadherin expression in intestinal epithelium in inflammatory bowel disease
Yang, Q., Zhong, H., Zhu, Z., Chen, J., & Deng, B. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178262 · Cited by 3
Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy
Iglesias, M., Badia-Ramentol, J., Martínez‐Ciarpaglini, C., Linares, J., Tarazona, N., Mulet-Margalef, N., Tornero-Piñero, P., Sallent-Aragay, A., Recort-Bascuas, A., Gibert, J., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-336804 · Cited by 3
Self-citation
Targeting fibroblast TXNDC5 resolves tumor desmoplasia and PD-1 resistance in colorectal cancer with mesenchymal traits
Cheng, K.-L., Chen, C., Yu, S.-H., Liang, H., Tsai, Y.-W., Hung, C., Lin, Y., Lee, G.-H., Chen, P. S., Tang, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74073-1 · Cited by 4
Exploring MAP2K3 as a prognostic biomarker and potential immunotherapy target in glioma treatment
Pu, B., Feng, S., Gu, L., Smerin, D., Jian, Z., Xiong, X., & Wei, L. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1387743 · Cited by 3
Lentinula Edodes Cultured Extract Regulates Immune Stress During Puberty and Modulates MicroRNAs Involved in Mammary Gland Development and Breast Cancer Suppression
Yasavoli‐Sharahi, H., Shahbazi, R., Alsadi, N., Robichaud, S., Kambli, D. B., Izadpanah, A., Mohsenifar, Z., & Matar, C. (2024) · Cancer Medicine · doi:10.1002/cam4.70277 · Cited by 3
Association of dietary inflammatory index with gynecological cancers in NHANES 2011–2018
Chen, C., Zheng, M., Dong, X., Zhang, P., Bao, Z., Cao, Y., Liu, Y., Yan, J., Guo, Y., & Zeng, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1560987 · Cited by 3
Sialyl-Tn expression correlates with reduced c-Myc and immune modulation in triple negative breast cancer
Lourenço, R. A., Barreira, D. F., Lopes, C., Granjo, P., Rodrigues, A. S., Silva, Z., Martins, M., Grosso, A. R., & Videira, P. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-21496-3 · Cited by 3
Insights into the Impact of Hesitancy on Cancer Care and COVID-19
Visweshwar, N., Rico, J. F., Ayala, I. A., Jaglal, M. V., Laber, D. A., Ammad-ud-din, M., Sokol, L., Sotomayor, E. M., & Manoharan, A. (2023) · Cancers · doi:10.3390/cancers15123115 · Cited by 3
Long-lasting complete response to SHR-1701 plus famitinib in refractory advanced gallbladder cancer: A case report
Yi, L., Zhu, X., Xie, J., & Meng, Z. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2294575 · Cited by 3
In vitro screening methods of novel immune checkpoint inhibitors related to T cell infiltration and anti-PD-1 resistance
He, Z., Zhou, X., Xiao, Y., & Gao, Y. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.07.006 · Cited by 4
Cytokine-driven cancer immune evasion mechanisms
Arenas, E. J. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.01.004 · Cited by 5
Exploring the molecular pathways of advanced rectal cancer: A focus on genetic, RNA, and biological technique
Zafar, A., Khalid, M., Alsaidan, O. A., & Mujtaba, M. A. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155956 · Cited by 3
Editorial: Dual role of inflammatory mediators in cancer immunotherapy
Wang, X., He, J., & Pan, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1229355 · Cited by 3
Reduced lung metastasis in endothelial cell-specific transforming growth factor β type II receptor-deficient mice with decreased CD44 expression
Hanada, K., Saito, Y., Takagi, T., Go, M., Nakano, Y., Inagawa, T., Hirai, H., Fruttiger, M., Itoh, S., & Itoh, F. (2024) · iScience · doi:10.1016/j.isci.2024.111502 · Cited by 4
Synthesis and biological evaluation of 4-((3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)quinoline derivatives as novel potential transforming growth factor-β type 1 receptor inhibitors for hepatocellular carcinoma
Liu, S., Wang, F., Zhang, C., Jiang, H., & Liu, C. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108156 · Cited by 2
The atypical KRAS Q22K mutation directs TGF ‐β response towards partial epithelial‐to‐mesenchymal transition in patient‐derived colorectal cancer tumoroids
Mair, T., König, P., Mijović, M., Kalla, J., Baskan, A., Tran, L., Draganić, K., Saldaña, P. M., Malla, C. U. P., Pfneissl, J., et al. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70014 · Cited by 2
Comprehensive assessment of computational methods for cancer immunoediting
He, S., Sun, S., Liu, K., Pang, B., & Xiao, Y. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101006 · Cited by 2
Exploring the potential of CAR-NK cell therapy in the management of head and neck cancer (HNC): a narrative review
Zare, E., Mostafavi, S., Norouzi, N., Larijani, A., Mirkalaie, S. M. M., FallahMortezaNejad, S. A., Jafari, M., Shahabinejad, E., Lasboo, M. A., & Anvari, S. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003002 · Cited by 2
Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma
Zhang, K., Xie, H., Zhao, F., & Huang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1564784 · Cited by 2
TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy
Teng, Q., Wang, N., Lei, H., Tong, T., Guan, Y., Huang, M., Cao, F., Xu, B., Yang, J., Huo, Y., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04103-2 · Cited by 2
The Good, the Bad, or Both? Unveiling the Molecular Functions of LINC01133 in Tumors
Júnior, L. T., & Sogayar, M. C. (2025) · Non-Coding RNA · doi:10.3390/ncrna11040058 · Cited by 2
Association of different autoimmune diseases with gastric cancer incidence and risk: a global population-based analysis
Cheng, J., Cai, M., & Wang, G. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003937 · Cited by 2
Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression
Chava, S., Bugide, S., Malvi, P., DeMarco, K. D., Ma, B., Parikh, C. N., Ruscetti, M. A., Zajac, A. J., Cai, G., Gupta, R., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00357-6 · Cited by 4
Synthesis and characterization of new P2X7 receptor antagonists as antitumor agents
Grignolo, M., Spinaci, A., Ricci, L., Pegoraro, A., Ruo, L., Lambertucci, C., Vitone, D., Leopoldo, M., Lacivita, E., Fortuna, F., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119185 · Cited by 2
Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trial
Pan, Y., Yang, X., Zhou, Q., Zhao, Y. W., Han, G., Pang, Q., Zhang, Z., Wang, Q., Yao, J., Wang, H., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02779-1 · Cited by 2
Tumor-induced immune escape mechanisms and translational immunotherapeutic strategies
Yousefi, M., Farahpour, M. R., Alizadeh, N., Abedian, A., & Baradaran, B. (2026) · Discover Oncology · doi:10.1007/s12672-026-05518-8 · Cited by 2
Targeting the JMJD6/TGF-β axis in prostate cancer by immunotherapy: A potential treatment based on RNA splicing
Ni, Y., Xu, J., & Tong, D. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111018 · Cited by 2
[Advances of Immunotherapy Resistance and Coping Strategies in Non-small Cell Lung Cancer].
Jing, Y., Zeng, H., Cheng, R., Tian, P., & Li, Y. (2023) · PubMed Central · doi:10.3779/j.issn.1009-3419.2023.102.03 · Cited by 2
Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinoma
Peng, Y., Yang, J., Ao, J., Li, Y., Shen, J., He, X., Tang, D., Chu, C., Liu, C., & Weng, L. (2025) · eLife · doi:10.7554/elife.97335.3 · Cited by 2
Significance of preoperative levels biomarkers TGF-β1 and CA 19-9 in distinguishing benign and malignant pancreatic neoplasms
Кryvoruchko, І. А., Lurin, I. A., Krasnoselskyi, M. V., Honcharova, N. М., Habeeb, T. A. A. M., Nessonova, M., Honcharov, A., Kuzmenko, О. V., & Kolesnyk, V. P. (2024) · Український радіологічний та онкологічний журнал · doi:10.46879/ukroj.4.2024.428-447 · Cited by 2
Unveiling the immunological landscape: comprehensive characterization of neoantigen-reactive immune cells in neoantigen cancer vaccines
Liu, W., Su, H. L., Guo, P., Hong, L., Hao, X., & Li, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1537947 · Cited by 2
Overcoming TGFβ and activin A suppression boosts NK cell antitumor function
(2025) · Nature Immunology · doi:10.1038/s41590-025-02112-y · Cited by 2
DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden
Gong, J., Lee, J., Han, Y.-H., & Cho, K. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412310122 · Cited by 2
Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinomaPreprint
Peng, Y., Yang, J., Ao, J., Li, Y., Shen, J., He, X., Tang, D., Chu, C., Liu, C., & Weng, L. (2024) · eLife · doi:10.7554/elife.97335.2 · Cited by 2
Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node status
DeTemple, V. K., Ritter, C., Srinivas, N., Spassova, I., Gambichler, T., Hüning, S., Gräger, N., Gutzmer, R., Bröcker, E., Ugurel, S., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.115054 · Cited by 1
High-throughput sequencing reveals twelve cell death pattern prognostic target genes as potential drug-response-associated genes in the treatment of colorectal cancer cells with palmatine hydrochloride
Luo, S., Xu, J., Mo, C., Gong, W., Li, C., Hou, X., & Ou, M. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2024-0378 · Cited by 1
Clinical development complexity of TGF-β inhibition: From fibrosis to cancer immunotherapy
Gallo-Oller, G., Guillén-Antonini, M. I., & Dotor, J. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.01.005 · Cited by 2
Mental distress and inflammation in bladder cancer: The nerve makes things less vague
Mikolášková, I., Gidron, Y., Ďurmanová, V., Suchánková, M., Bucová, M., & Hunáková, Ľ. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100995 · Cited by 2
Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma
Zhang, B., Xie, Y., Shen, M., Sun, J., Li, Y., Zhang, J., Li, Q., Chen, C., Chen, Z., Wang, W. T., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015469 · Cited by 1
Friend or foe: The paradoxical roles of cancer‐associated fibroblasts in tumour immunotherapy
Xiong, M., Jiang, A., Li, Z., Wong, H. Z. H., Zhang, J., Lin, A., Feng, S., & Luo, P. (2025) · Clinical and Translational Discovery · doi:10.1002/ctd2.70056 · Cited by 1
Evolving role of deubiquitinating enzymes in oral cancer (Review)
Wang, Z., Cheng, S., Wei, J., Hu, J., Li, F., & Yang, W. (2025) · Oncology Letters · doi:10.3892/ol.2025.15100 · Cited by 1
Peripheral blood CD4+CD25+ T lymphocytes and TGF-β predict the prognosis in relapsed/refractory multiple myeloma treated with daratumumab
Xue, H., Fang, W., & Li, R. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152373 · Cited by 1
A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer
Dai, M., Shi, Y., Zhao, H., Hu, Y., Cong, X., Yu, B., Zhang, H., Yu, X., & Wu, H. C. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02280-2 · Cited by 1
Unraveling the multifaceted landscape of hepatocellular carcinoma evolution: From pivotal genetic drivers to therapeutic horizons
Liu, J., Xiong, S., Zhao, Y., Yang, X., Shen, J., He, Z., Zhang, Y., Zhang, Y., Guo, L., & Liang, T. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117229 · Cited by 4
Multi-omics reveals immune features in immune and non-immune cells, an IFN-γ/IFN-α-B2M positive feedback loop, and targeted metabolic therapy in multiple myeloma
Li, C., Liao, Y., Xu, L., & Chen, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1575079 · Cited by 1
Clinical value of serum TNF-α and IL-2R as treatment predictive and prognostic biomarkers in metastatic colorectal cancer
Tian, J., Chang, J., Chen, Z., & Li, W. (2025) · Cytokine · doi:10.1016/j.cyto.2025.157046 · Cited by 1
Targeting Tumor‐Immune Microenvironment with Organoid and Organ‐on‐a‐Chip: An Updated Review
Madani, S., Holman, J. B., Rajput, M. U., Ali, S. W., Shi, Z., Qiu, B., Zhang, A., Li, C., & Ding, W. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202501704 · Cited by 1
Roseburia intestinalis-derived inosine improves intestinal motility by activating TGF-β1/p-Smad3/Transgelin signaling axis
Dong, X., Zhang, H., Chen, M., Liu, H., Sun, M., Jiang, K., Ruan, H., Wang, B., & Zhong, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07366-6 · Cited by 1
Inverse game theory characterizes frequency-dependent selection driven by karyotypic diversity in triple-negative breast cancer
Veith, T. A., Beck, R. J., Brown, J. S., & Andor, N. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013897 · Cited by 1
Targeted delivery of TGF-β inhibitor via LHRH-NanoTi reverses the NAT10/ac4C-mediated cisplatin-induced immunosuppressive tumor microenvironment in ovarian cancer
Lv, F., Zhao, Q., Zou, R., Ye, X., Shen, Y., Meng, L., Guo, J., Wang, Y., Zheng, Y., Liu, Y., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04631-8 · Cited by 1
Universal off-the-shelf TGF-β1-knockout whole-tumor cell vaccine overcomes immunotherapy resistance in pMMR/MSS tumors
Yang, W., Dong, Z., Xiong, Q., Ren, Y., Zhang, L., Liu, Y., Han, J., Tian, T., Su, X., Shi, G., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.001 · Cited by 1
Targeting FAP/CAFs to rewire immune-excluded and resistant tumor niches
Wang, Y., Zhao, Y., Zhou, C., & Wang, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1812674 · Cited by 1
TGF-β2 drives lipid droplet accumulation in chondrocytes through the TβRI/p-smad3/fabp5 axis
Wei, J., Pi, C., Qi, Y., Yang, W., Sun, J., Xu, X., & Xie, J. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113317 · Cited by 1
Dissecting immunosuppressive microenvironment in chemotherapy-resistant colorectal cancer through single-cell transcriptomic analysis
Xi, J., Li, Z., Liu, Y., Niu, W., Yu, B., Li, Z., & Wang, G. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102889 · Cited by 1
GLG1 in cancer-associated fibroblasts promotes bladder cancer growth while limiting tumor apoptosis
Liu, J., Zhou, Z., Zhang, B., Liu, R., & Zhang, Y. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02439-3 · Cited by 1
Radiation therapy: An old dog learning new tricks
Sato, A., Kraynak, J., Marciscano, A. E. E., & Galluzzi, L. (2022) · Methods in cell biology · doi:10.1016/s0091-679x(22)00139-x · Cited by 1
Development of a transcriptome-based determination of innate immune suppressor (TDIS) assay as an in vitro test for immunotoxicity
Quan, H., Jun, H., Kim, K., Lee, S. K., Heo, Y., Seok, S. H., & Na, Y. R. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03406-y · Cited by 1
Harnessing the Tumor Microenvironment for Cancer Immunotherapy
Fru, P. N., Nweke, E. E., & Augustine, T. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_183-1 · Cited by 1
Quantum Medicine and the Immune System
Barassi, G., Proietti, M., Spaggiari, P., & Colombo, A. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_287-1 · Cited by 1
TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis
Tsumuraya, H., Okayama, H., Katagata, M., Matsuishi, A., Fukai, S., Ito, M., Sakamoto, W., Saito, M., Momma, T., Nakajima, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094626 · Cited by 1
TGF-β signaling pathway in the regulations of development and disease
Sun, H., Wei, S., & Xi, Q. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-0326 · Cited by 3
MAD2L2 overexpression attenuates the effects of TNF-α-induced migration and invasion capabilities in colorectal cancer cells
Sun, H., WANG, H., HAO, Y., Li, X., LING, J., Wang, H., WANG, F., & Xu, F. (2024) · Biocell · doi:10.32604/biocell.2024.052451 · Cited by 1
Withametelin inhibits TGF-β induced Epithelial-to-Mesenchymal Transition and Programmed-Death Ligand-1 expression in vitro
Fathima, A., Jahromi, M. A. F., Begum, A. S., & Trinath, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1435516 · Cited by 1
BMPR1A promotes the proliferation of colorectal cancer cells through the activation of Smad1
Zhou, P., Li, W., Ye, M., Chen, C., & Wang, Y. (2025) · ONCOLOGIE · doi:10.1515/oncologie-2024-0534 · Cited by 1
A battle between two biological singularities: Immune response vs. cancer
Katakai, T., & Okazaki, T. (2024) · Biophysics and Physicobiology · doi:10.2142/biophysico.bppb-v21.s006 · Cited by 1

Authors: Tauriello, D. V. F., Sancho, E., & Batlle, E.
Affiliations: Radboud University Medical Center (NL)
Institute for Research in Biomedicine (ES)
Institució Catalana de Recerca i Estudis Avançats (ES)
Corresponding author: Tauriello, Daniele V. F.
Batlle, Eduard
ORCID: Tauriello, Daniele V. F.
Sancho, Elena
Batlle, Eduard
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2021-10-20
Volume: 22
Issue: 1
Pages: 25-44
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-021-00413-6
OpenAlex: W3206061095
Cited by: 377
References: 320
Citations by year: 2026: 65 · 2025: 101 · 2024: 93 · 2023: 61 · 2022: 55 · 2021: 2
FWCI: 5.58
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
Radboud Repository (Radboud University) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: TGF-beta signaling, tumor immune microenvironment, immune evasion, cancer-associated fibroblasts, innate immune suppression, TGF-beta inhibition, cancer immunotherapy, immune checkpoint blockade
MeSH terms: Humans, Immunotherapy, Neoplasms, Transforming Growth Factor beta, Immune Evasion, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Overcoming TGFβ-mediated immune evasion in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks